a phase iii trial of pembrolizumab as adjuvant treatment for renal cell carcinoma
Published 6 years ago • 552 plays • Length 3:01Download video MP4
Download video MP3
Similar videos
-
2:23
overview of a phase iii trial of pembrolizumab plus axitinib in rcc
-
3:03
adjuvant pembrolizumab improves rcc disease-free survival | toni choueiri
-
0:35
the latest developments in adjuvant therapy for rcc
-
1:08
clinical trials in adjuvant rcc
-
1:03
potential of adjuvant therapy for rcc
-
2:23
s-trac phase iii trial of sunitinib as adjuvant therapy in high-risk renal cell cancer patients
-
1:00
adjuvant pembrolizumab in kidney cancer from keynote 564
-
0:39
phase i/ii study of adapt-001 plus an ici for patients with immune refractory cancers
-
1:14
dr. hutson gives an analysis of the phase iii atlas trial in rcc
-
2:22
adjuvant pembrolizumab and survival in renal-cell carcinoma | nejm
-
0:43
dr. rini on adjuvant immunotherapy in renal cell carcinoma
-
2:18
dr. pal discusses adjuvant therapy for renal cell carcinoma
-
2:16
dr. rini on axitinib for treatment of metastatic renal cell carcinoma
-
5:33
keynote-564: pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for patients with...
-
3:47
other clinical trials in renal cell carcinoma
-
0:51
novel immune therapeutics for adjuvant treatment of kidney cancer
-
0:55
selecting patients with renal cell carcinoma for adjuvant sunitinib therapy
-
0:53
the role of icis in the adjuvant setting for rcc